These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28492219)

  • 21. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of measles-rubella-zoster reaction, oligoclonal IgG bands, oligoclonal kappa free light chains and kappa index in multiple sclerosis.
    Zondra Revendova K; Svub K; Bunganic R; Pelisek O; Volny O; Ganesh A; Bar M; Zeman D; Kusnierova P
    Mult Scler Relat Disord; 2024 Jan; 81():105125. PubMed ID: 37980789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
    Monreal E; Fernández-Velasco JI; García-Soidán A; Sainz de la Maza S; Espiño M; Villarrubia N; Rodríguez-Jorge F; Chico-García JL; Sainz-Amo R; Masjuan J; Costa-Frossard L; Villar LM
    Front Immunol; 2023; 14():1288169. PubMed ID: 37954589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases.
    Michetti L; Maffina F; Ravasio R; Barcella V; Radaelli M; Chiudinelli L; Sessa M; Alessio MG
    J Neuroimmunol; 2023 Jun; 379():578091. PubMed ID: 37210840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis.
    Fischer C; Arneth B; Koehler J; Lotz J; Lackner KJ
    Clin Chem; 2004 Oct; 50(10):1809-13. PubMed ID: 15271859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of monoclonal gammopathy and isoelectric focusing pattern 5 on the free light chain kappa diagnostics in cerebrospinal fluid.
    Hannich MJ; Konen FF; Gag K; Alkhayer A; Türker SN; Budde K; Nauck M; Wurster U; Dressel A; Skripuletz T; Süße M
    Clin Chem Lab Med; 2024 Jul; ():. PubMed ID: 39039726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
    Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
    J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid.
    Arneth B; Birklein F
    Acta Neurol Scand; 2009 Jan; 119(1):39-44. PubMed ID: 18573131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Elovaara I; Seppälä I; Palo J; Sulkava R; Erkinjuntti T
    Acta Neurol Scand; 1988 May; 77(5):397-401. PubMed ID: 3137767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oligoclonal bands: clinical utility and interpretation cues.
    Carta S; Ferraro D; Ferrari S; Briani C; Mariotto S
    Crit Rev Clin Lab Sci; 2022 Sep; 59(6):391-404. PubMed ID: 35277112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter study.
    Bernardi G; Biagioli T; Malpassi P; De Michele T; Vecchio D; Repice AM; Lugaresi A; Mirabella M; Torri Clerici V; Crespi I
    Mult Scler; 2022 Aug; 28(9):1364-1372. PubMed ID: 34965771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
    Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
    PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kappa free light chains: Diagnostic performance in multiple sclerosis and utility in a clinical laboratory.
    Alves Martins D; Lopes J; Martins da Silva A; Morais CI; Vasconcelos J; Lima I; Carneiro C; Neves E
    Clin Chim Acta; 2022 Mar; 528():56-64. PubMed ID: 35092724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases.
    Konen FF; Schwenkenbecher P; Jendretzky KF; Gingele S; Witte T; Sühs KW; Grothe M; Hannich MJ; Süße M; Skripuletz T
    Brain Sci; 2022 Apr; 12(4):. PubMed ID: 35448006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
    Hegen H; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):182-195. PubMed ID: 36527368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders.
    Ferraro D; Bedin R; Natali P; Franciotta D; Smolik K; Santangelo M; Immovilli P; Camera V; Vitetta F; Gastaldi M; Trenti T; Meletti S; Sola P
    Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33096861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.
    Konen FF; Schwenkenbecher P; Jendretzky KF; Gingele S; Sühs KW; Tumani H; Süße M; Skripuletz T
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities.
    Levraut M; Landes C; Mondot L; Cohen M; Bresch S; Brglez V; Seitz-Polski B; Lebrun-Frenay C
    Front Immunol; 2022; 13():864133. PubMed ID: 35401550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.